Delaying surgery for patients with a previous SARS-CoV-2 infection

COVIDSurg Collaborative, J Bennetts, T Bright, M Brooke-Smith, Yick Lam, David Watson

Research output: Contribution to journalLetterpeer-review

77 Citations (Scopus)


With at least 28 elective million operations delayed during the first three months of the COVID-19 pandemic, the number of patients who will require surgery after a previous SARS-CoV-2 infection is likely to increase rapidly1. Operating on patients with an active perioperative SARS-CoV-2 infection is now known to carry a very high pulmonary complication and mortality rate2. Urgent information is needed to
guide whether postponing surgery in patients with a previous SARS-CoV-2 infection leads to a clinical benefit, and the optimal length of delay.
Original languageEnglish
Pages (from-to)e601-e602
Number of pages2
JournalBritish Journal of Surgery
Issue number12
Publication statusPublished - Nov 2020


  • adult respiratory distress syndrome
  • asymptomatic infection
  • cancer surgery
  • clinical outcome
  • cohort analysis
  • coronavirus disease 2019
  • elective surgery
  • human
  • Letter
  • major clinical study
  • mortality
  • multicenter study
  • pneumonia
  • postoperative complication
  • priority journal
  • propensity score
  • prospective study
  • real time reverse transcription polymerase chain reaction
  • therapy delay
  • throat culture
  • comorbidity
  • neoplasm
  • pandemic
  • procedures
  • time to treatment
  • Comorbidity
  • COVID-19
  • Humans
  • Neoplasms
  • Pandemics
  • SARS-CoV-2
  • Surgical Procedures
  • Operative
  • Time-to-Treatment


Dive into the research topics of 'Delaying surgery for patients with a previous SARS-CoV-2 infection'. Together they form a unique fingerprint.

Cite this